Neocrin's Series B Round

Neocrin raised a round of funding on January 01, 1995.

Researcher and developer of a minimally invasive, encapsulated cellular transplant device for the treatment of diabetes. The company sold its assets to Novocell.…

Articles about Neocrin's Series B Round: